FDA limits use of Johnson and Johnson's Janssen COVID-19 vaccine

Upworthy

05 May 2022 0 shares 3 views

FDA limits use of Johnson and Johnson's Janssen COVID-19 vaccine

Upworthy

Published 05 May 2022

The FDA announced on Thursday it is limiting the use of the Janssen COVID-19 vaccine to people 18 or older after an investigation found that those who received the jab were at risk of blood clots.

#janssencovid #janssencovid19

Full Article

FDA finally admits that covid vaccines cause blood clots

NaturalNews.com 10 May 2022

(Natural News) The U.S. Food and Drug Administration (FDA) has altered its guidance for the Wuhan coronavirus (Covid-19)..

Breakfast Briefing: 5 things for PR pros to know on Friday morning
PRWeek 06 May 2022
Covid-19 vaccine: US FDA limits use of Johnson and Johnson due to blood clot risk
DNA 06 May 2022
US FDA limits use of Johnson & Johnson Covid-19 vaccine over blood clot risk
Zee News 06 May 2022
FDA Further Limits Johnson & Johnson Covid Vaccine
NYTimes.com 06 May 2022

More coverage

FDA restricts use of Johnson & Johnson COVID vaccine due to blood clot risk

USATODAY.com 06 May 2022

According to the FDA, the J & J COVID-19 vaccine should only be given to people who can't receive other vaccines or those who..

FDA dramatically narrows use of Johnson & Johnson Covid-19 vaccine
Upworthy 06 May 2022
FDA Drastically Reduces Use Of Johnson & Johnson Vaccine Over Blood Clots
Daily Caller 06 May 2022
FDA restricts J&J's COVID-19 vaccine due to blood clot risk
SeattlePI.com 05 May 2022
FDA limits use of J&J vaccine over rare blood clots
Washington Post 05 May 2022

FDA limits use of Johnson and Johnson's Janssen COVID-19 vaccine

FDA limits use of Johnson and Johnson's Janssen COVID-19 vaccine

You might like

Related news coverage

FDA finally admits that covid vaccines cause blood clots

Advertisement

More coverage

FDA restricts use of Johnson & Johnson COVID vaccine due to blood clot risk